Radiology of fibrosis part II: abdominal organs.
Abdominal organs
Fibrosis
Imaging
Journal
Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741
Informations de publication
Date de publication:
02 Jul 2024
02 Jul 2024
Historique:
received:
12
02
2024
accepted:
25
05
2024
medline:
3
7
2024
pubmed:
3
7
2024
entrez:
3
7
2024
Statut:
epublish
Résumé
Fibrosis is the aberrant process of connective tissue deposition from abnormal tissue repair in response to sustained tissue injury caused by hypoxia, infection, or physical damage. It can affect almost all organs in the body causing dysfunction and ultimate organ failure. Tissue fibrosis also plays a vital role in carcinogenesis and cancer progression. The early and accurate diagnosis of organ fibrosis along with adequate surveillance are helpful to implement early disease-modifying interventions, important to reduce mortality and improve quality of life. While extensive research has already been carried out on the topic, a thorough understanding of how this relationship reveals itself using modern imaging techniques has yet to be established. This work outlines the ways in which fibrosis shows up in abdominal organs and has listed the most relevant imaging technologies employed for its detection. New imaging technologies and developments are discussed along with their promising applications in the early detection of organ fibrosis.
Identifiants
pubmed: 38956593
doi: 10.1186/s12967-024-05346-w
pii: 10.1186/s12967-024-05346-w
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
610Informations de copyright
© 2024. The Author(s).
Références
Chandler C, Liu T, Buckanovich R, Coffman LG. The double edge sword of fibrosis in cancer. Transl Res. 2019;209:55–67. https://doi.org/10.1016/j.trsl.2019.02.006 .
doi: 10.1016/j.trsl.2019.02.006
pubmed: 30871956
pmcid: 6545239
Roman J, Barnes TR, Kervitsky DJ, et al. The fibrosis across organs symposium: a roadmap for future research priorities. Am J Med Sci. 2019;357(5):405–10. https://doi.org/10.1016/j.amjms.2019.02.014 .
doi: 10.1016/j.amjms.2019.02.014
pubmed: 31010467
pmcid: 7219529
Kumar V, Abbas AK, Aster JC. Robbins and Cotran: pathologic basis of disease. 8th ed. Philadelphia: Elsevier Saunders; 2005.
Henderson NCRF, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587(7835):555–66. https://doi.org/10.1038/s41586-020-2938-9 .
doi: 10.1038/s41586-020-2938-9
pubmed: 33239795
pmcid: 8034822
Fitridge R, Thompson M. Mechanisms of vascular disease: a reference book for vascular specialists. Adelaide: University of Adelaide Press; 2011.
doi: 10.1017/UPO9781922064004
Reinke JM, Sorg H. Wound repair and regeneration. Eur Surg Res. 2012;49(1):35–43. https://doi.org/10.1159/000339613 .
doi: 10.1159/000339613
pubmed: 22797712
Landén NX, Li D, Ståhle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci. 2016;73(20):3861–85. https://doi.org/10.1007/s00018-016-2268-0 .
doi: 10.1007/s00018-016-2268-0
pubmed: 27180275
pmcid: 5021733
Bitto N, Liguori E, La Mura V. Coagulation, microenvironment and liver fibrosis. Cells. 2018. https://doi.org/10.3390/cells7080085 .
doi: 10.3390/cells7080085
pubmed: 30042349
pmcid: 6115868
Fiorucci S, Antonelli E, Distrutti E, et al. PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation. Hepatology. 2004;39(2):365–75. https://doi.org/10.1002/hep.20054 .
doi: 10.1002/hep.20054
pubmed: 14767989
Pant A, Kopec AK, Luyendyk JP. Role of the blood coagulation cascade in hepatic fibrosis. Am J Physiol Gastrointest Liver Physiol. 2018;315(2):G171-g176. https://doi.org/10.1152/ajpgi.00402.2017 .
doi: 10.1152/ajpgi.00402.2017
pubmed: 29723040
pmcid: 6139645
Gonzalez AC, Costa TF, Andrade ZA, Medrado AR. Wound healing—a literature review. An Bras Dermatol. 2016;91(5):614–20. https://doi.org/10.1590/abd1806-4841.20164741 .
doi: 10.1590/abd1806-4841.20164741
pubmed: 27828635
pmcid: 5087220
Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99–118. https://doi.org/10.1146/annurev-pathol-121808-102144 .
doi: 10.1146/annurev-pathol-121808-102144
pubmed: 20078217
pmcid: 4166495
Kulasekaran P, Scavone CA, Rogers DS, Arenberg DA, Thannickal VJ, Horowitz JC. Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation. Am J Respir Cell Mol Biol. 2009;41(4):484–93. https://doi.org/10.1165/rcmb.2008-0447OC .
doi: 10.1165/rcmb.2008-0447OC
pubmed: 19188658
pmcid: 2746991
Hinz B, Gabbiani G. Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives. F1000 Biol Rep. 2010;2:78. https://doi.org/10.3410/b2-78 .
doi: 10.3410/b2-78
pubmed: 21170369
pmcid: 2998803
Barry K. Chronic pancreatitis: diagnosis and treatment. Am Fam Phys. 2018;97(6):385–93.
Beyer G, Habtezion A, Werner J, Lerch MM, Mayerle J. Chronic pancreatitis. Lancet. 2020;396(10249):499–512. https://doi.org/10.1016/s0140-6736(20)31318-0 .
doi: 10.1016/s0140-6736(20)31318-0
pubmed: 32798493
Xue J, Sharma V, Hsieh MH, et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun. 2015;6:7158. https://doi.org/10.1038/ncomms8158 .
doi: 10.1038/ncomms8158
pubmed: 25981357
Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1252–61. https://doi.org/10.1053/j.gastro.2013.01.068 .
doi: 10.1053/j.gastro.2013.01.068
pubmed: 23622135
Singh VK, Yadav D, Garg PK. Diagnosis and management of chronic pancreatitis: a review. JAMA. 2019;322(24):2422–34. https://doi.org/10.1001/jama.2019.19411 .
doi: 10.1001/jama.2019.19411
pubmed: 31860051
Huang CT, Lin CK, Lee TH, Liang YJ. Pancreatic fibrosis and chronic pancreatitis: mini-review of non-histologic diagnosis for clinical applications. Diagnostics (Basel). 2020. https://doi.org/10.3390/diagnostics10020087 .
doi: 10.3390/diagnostics10020087
pubmed: 33383705
pmcid: 7824214
Kamat R, Gupta P, Rana S. Imaging in chronic pancreatitis: state of the art review. Indian J Radiol Imaging. 2019;29(2):201–10. https://doi.org/10.4103/ijri.IJRI_484_18 .
doi: 10.4103/ijri.IJRI_484_18
pubmed: 31367093
pmcid: 6639861
Parakh A, Tirkes T. Advanced imaging techniques for chronic pancreatitis. Abdom Radiol (NY). 2020;45(5):1420–38. https://doi.org/10.1007/s00261-019-02191-0 .
doi: 10.1007/s00261-019-02191-0
pubmed: 31428813
pmcid: 7028513
Siddiqi AJ, Miller F. Chronic pancreatitis: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR. 2007;28(5):384–94. https://doi.org/10.1053/j.sult.2007.06.003 .
doi: 10.1053/j.sult.2007.06.003
pubmed: 17970554
Indira K, Murdani A, Marcellus S. Chronic pancreatitis. Indones J Gastroenterol Hepatol Dig Endosc. 2020;19(2):107–17. https://doi.org/10.24871/1922018107-117 .
doi: 10.24871/1922018107-117
Yamashita Y, Ashida R, Kitano M. Imaging of fibrosis in chronic pancreatitis. Front Physiol. 2021;12: 800516. https://doi.org/10.3389/fphys.2021.800516 .
doi: 10.3389/fphys.2021.800516
pubmed: 35082692
Iglesias-Garcia J, Domínguez-Muñoz JE, Castiñeira-Alvariño M, Luaces-Regueira M, Lariño-Noia J. Quantitative elastography associated with endoscopic ultrasound for the diagnosis of chronic pancreatitis. Endoscopy. 2013;45(10):781–8. https://doi.org/10.1055/s-0033-1344614 .
doi: 10.1055/s-0033-1344614
pubmed: 24019131
Mondal U, Henkes N, Patel S, Rosenkranz L. Endoscopic ultrasound elastography: current clinical use in pancreas. Pancreas. 2016;45(7):929–33. https://doi.org/10.1097/mpa.0000000000000595 .
doi: 10.1097/mpa.0000000000000595
pubmed: 26825864
Nabavizadeh A, Payen T, Iuga AC, et al. Noninvasive Young’s modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME) in vivo. Theranostics. 2020;10(10):4614–26. https://doi.org/10.7150/thno.37965 .
doi: 10.7150/thno.37965
pubmed: 32292518
pmcid: 7150482
Meseeha M, Attia M. Endoscopic retrograde cholangiopancreatography. StatPearls. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023
Stevens KJ, Lisanti C. Pancreas imaging. StatPearls. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.
Coenegrachts K, Van Steenbergen W, De Keyzer F, et al. Dynamic contrast-enhanced MRI of the pancreas: initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging. 2004;20(6):990–7. https://doi.org/10.1002/jmri.20212 .
doi: 10.1002/jmri.20212
pubmed: 15558558
Miller FH, Keppke AL, Wadhwa A, Ly JN, Dalal K, Kamler VA. MRI of pancreatitis and its complications: part 2, chronic pancreatitis. AJR Am J Roentgenol. 2004;183(6):1645–52. https://doi.org/10.2214/ajr.183.6.01831645 .
doi: 10.2214/ajr.183.6.01831645
pubmed: 15547204
Manikkavasakar S, AlObaidy M, Busireddy KK, et al. Magnetic resonance imaging of pancreatitis: an update. World J Gastroenterol. 2014;20(40):14760–77. https://doi.org/10.3748/wjg.v20.i40.14760 .
doi: 10.3748/wjg.v20.i40.14760
pubmed: 25356038
pmcid: 4209541
Semelka RC, Shoenut JP, Kroeker MA, Micflikier AB. Chronic pancreatitis: MR imaging features before and after administration of gadopentetate dimeglumine. J Magn Reson Imaging. 1993;3(1):79–82. https://doi.org/10.1002/jmri.1880030114 .
doi: 10.1002/jmri.1880030114
pubmed: 8428105
Aydın MM, Akçalı KC. Liver fibrosis. Turk J Gastroenterol. 2018;29(1):14–21. https://doi.org/10.5152/tjg.2018.17330 .
doi: 10.5152/tjg.2018.17330
pubmed: 29391303
pmcid: 6322608
Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37–55. https://doi.org/10.1016/j.mam.2018.09.002 .
doi: 10.1016/j.mam.2018.09.002
pubmed: 30213667
Sharma A, Nagalli S. Chronic Liver Disease. StatPearls. StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.
BDJA. VM. Tables of Summary Health Statistics for U.S. Adults: 2018.
Friedman SL, Bansal MB. Reversal of hepatic fibrosis—fact or fantasy? Hepatology. 2006;43(2 Suppl 1):S82–8. https://doi.org/10.1002/hep.20974 .
doi: 10.1002/hep.20974
pubmed: 16447275
Martínez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011;53(1):325–35. https://doi.org/10.1002/hep.24013 .
doi: 10.1002/hep.24013
pubmed: 21254180
Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004;99(6):1160–74. https://doi.org/10.1111/j.1572-0241.2004.30110.x .
doi: 10.1111/j.1572-0241.2004.30110.x
pubmed: 15180741
Lai M, Afdhal NH. Liver fibrosis determination. Gastroenterol Clin North Am. 2019;48(2):281–9. https://doi.org/10.1016/j.gtc.2019.02.002 .
doi: 10.1016/j.gtc.2019.02.002
pubmed: 31046975
Horowitz JM, Venkatesh SK, Ehman RL, et al. Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY). 2017;42(8):2037–53. https://doi.org/10.1007/s00261-017-1211-7 .
doi: 10.1007/s00261-017-1211-7
pubmed: 28624924
Chen JH, Chai JW, Shen WC. Magnetization transfer contrast imaging of liver cirrhosis. Hepatogastroenterology. 1999;46(29):2872–7.
pubmed: 10576364
Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer GZ. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol. 2015;21(41):11567–83. https://doi.org/10.3748/wjg.v21.i41.11567 .
doi: 10.3748/wjg.v21.i41.11567
pubmed: 26556987
pmcid: 4631961
Parakh A, Baliyan V, Sahani D. Dual-energy CT in focal and diffuse liver disease. Curr Radiol Rep. 2017;5:35. https://doi.org/10.1007/s40134-017-0226-8 .
doi: 10.1007/s40134-017-0226-8
Dana J, Venkatasamy A, Saviano A, et al. Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease. Hepatol Int. 2022;16(3):509–22. https://doi.org/10.1007/s12072-022-10303-0 .
doi: 10.1007/s12072-022-10303-0
pubmed: 35138551
Karanjia RN, Crossey MM, Cox IJ, et al. Hepatic steatosis and fibrosis: non-invasive assessment. World J Gastroenterol. 2016;22(45):9880–97. https://doi.org/10.3748/wjg.v22.i45.9880 .
doi: 10.3748/wjg.v22.i45.9880
pubmed: 28018096
pmcid: 5143756
Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis. Gut. 2020;69(7):1343–52. https://doi.org/10.1136/gutjnl-2018-317593 .
doi: 10.1136/gutjnl-2018-317593
pubmed: 32066623
Zhang YN, Fowler KJ, Ozturk A, et al. Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography. J Magn Reson Imaging. 2020;51(1):25–42. https://doi.org/10.1002/jmri.26716 .
doi: 10.1002/jmri.26716
pubmed: 30859677
Li S, Sun X, Chen M, et al. Liver fibrosis conventional and molecular imaging diagnosis update. J Liver. 2019;8(1):236.
doi: 10.35248/2167-0889.19.8.236
pubmed: 31341723
pmcid: 6653681
Romero-Gómez M, Gómez-González E, Madrazo A, et al. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology. 2008;47(3):810–6. https://doi.org/10.1002/hep.22112 .
doi: 10.1002/hep.22112
pubmed: 18098299
Moura Cunha G, Navin PJ, Fowler KJ, Venkatesh SK, Ehman RL, Sirlin CB. Quantitative magnetic resonance imaging for chronic liver disease. Br J Radiol. 2021;94(1121):20201377. https://doi.org/10.1259/bjr.20201377 .
doi: 10.1259/bjr.20201377
pubmed: 33635729
pmcid: 8506189
Pavlides M, Banerjee R, Sellwood J, et al. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol. 2016;64(2):308–15. https://doi.org/10.1016/j.jhep.2015.10.009 .
doi: 10.1016/j.jhep.2015.10.009
pubmed: 26471505
pmcid: 4751288
Petitclerc L, Sebastiani G, Gilbert G, Cloutier G, Tang A. Liver fibrosis: review of current imaging and MRI quantification techniques. J Magn Reson Imaging. 2017;45(5):1276–95. https://doi.org/10.1002/jmri.25550 .
doi: 10.1002/jmri.25550
pubmed: 27981751
Guglielmo FF, Venkatesh SK, Mitchell DG. Liver MR elastography technique and image interpretation: pearls and pitfalls. Radiographics. 2019;39(7):1983–2002. https://doi.org/10.1148/rg.2019190034 .
doi: 10.1148/rg.2019190034
pubmed: 31626569
Mariappan YK, Glaser KJ, Ehman RL. Magnetic resonance elastography: a review. Clin Anat. 2010;23(5):497–511. https://doi.org/10.1002/ca.21006 .
doi: 10.1002/ca.21006
pubmed: 20544947
pmcid: 3066083
Chan WPW, Mourad F, Leong RW. Crohn’s disease associated strictures. J Gastroenterol Hepatol. 2018;33(5):998–1008. https://doi.org/10.1111/jgh.14119 .
doi: 10.1111/jgh.14119
pubmed: 29427364
Rieder F, Brenmoehl J, Leeb S, Schölmerich J, Rogler G. Wound healing and fibrosis in intestinal disease. Gut. 2007;56(1):130–9. https://doi.org/10.1136/gut.2006.090456 .
doi: 10.1136/gut.2006.090456
pubmed: 17172588
pmcid: 1856649
Rieder F, Latella G, Magro F, et al. European Crohn’s and Colitis organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease. J Crohns Colitis. 2016;10(8):873–85. https://doi.org/10.1093/ecco-jcc/jjw055 .
doi: 10.1093/ecco-jcc/jjw055
pubmed: 26928961
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389(10080):1741–55. https://doi.org/10.1016/s0140-6736(16)31711-1 .
doi: 10.1016/s0140-6736(16)31711-1
pubmed: 27914655
Li J, Mao R, Kurada S, et al. Pathogenesis of fibrostenosing Crohn’s disease. Transl Res. 2019;209:39–54. https://doi.org/10.1016/j.trsl.2019.03.005 .
doi: 10.1016/j.trsl.2019.03.005
pubmed: 30981697
Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12(4):205–17. https://doi.org/10.1038/nrgastro.2015.34 .
doi: 10.1038/nrgastro.2015.34
pubmed: 25732745
Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, Sadeghi A, Nixon MR, Abdoli A, Abolhassani H, Alipour V. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30. https://doi.org/10.1016/s2468-1253(19)30333-4 .
doi: 10.1016/s2468-1253(19)30333-4
Le Fur M, Zhou IY, Catalano O, Caravan P. Toward molecular imaging of intestinal pathology. Inflamm Bowel Dis. 2020;26(10):1470–84. https://doi.org/10.1093/ibd/izaa213 .
doi: 10.1093/ibd/izaa213
pubmed: 32793946
pmcid: 7500524
Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol. 2018;113(4):481–517. https://doi.org/10.1038/ajg.2018.27 .
doi: 10.1038/ajg.2018.27
pubmed: 29610508
Veauthier B, Hornecker JR. Crohn’s disease: diagnosis and management. Am Fam Phys. 2018;98(11):661–9.
Pita I, Magro F. Advanced imaging techniques for small bowel Crohn’s disease what does the future hold. Ther Adv Gastroenterol. 2018;11:1756283x18757185. https://doi.org/10.1177/1756283x18757185 .
doi: 10.1177/1756283x18757185
Li XH, Mao R, Huang SY, et al. Characterization of degree of intestinal fibrosis in patients with Crohn disease by using magnetization transfer MR imaging. Radiology. 2018;287(2):494–503. https://doi.org/10.1148/radiol.2017171221 .
doi: 10.1148/radiol.2017171221
pubmed: 29357272
Zhong YK, Lu BL, Huang SY, et al. Cross-sectional imaging for assessing intestinal fibrosis in Crohn’s disease. J Dig Dis. 2020;21(6):342–50. https://doi.org/10.1111/1751-2980.12881 .
doi: 10.1111/1751-2980.12881
pubmed: 32418328
Stidham RW, Xu J, Johnson LA, et al. Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn’s disease. Gastroenterology. 2011;141(3):819-826.e1. https://doi.org/10.1053/j.gastro.2011.07.027 .
doi: 10.1053/j.gastro.2011.07.027
pubmed: 21784048
Stidham RW, Higgins PD. Imaging of intestinal fibrosis: current challenges and future methods. United Eur Gastroenterol J. 2016;4(4):515–22. https://doi.org/10.1177/2050640616636620 .
doi: 10.1177/2050640616636620
Harold KM, MacCuaig WM, Holter-Charkabarty J, et al. Advances in imaging of inflammation, fibrosis, and cancer in the gastrointestinal tract. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms232416109 .
doi: 10.3390/ijms232416109
pubmed: 36555749
pmcid: 9781634
Sun P, Zhu D, Li J, et al. Intravoxel incoherent motion diffusion-weighted imaging in quantitative evaluation of Ileal Crohn’s disease—a comparison with dynamic contrast-enhanced magnetic resonance imaging and ileocolonoscopy. Magn Reson Imaging. 2023;97:82–90. https://doi.org/10.1016/j.mri.2022.12.020 .
doi: 10.1016/j.mri.2022.12.020
pubmed: 36608907
Catalano OA, Wu V, Mahmood U, et al. Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn disease. Am J Nucl Med Mol Imaging. 2018;8(1):62–9.
pubmed: 29531862
pmcid: 5840324